HGHanwen Gu

Hanwen Gu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hanwen Gu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Huang

    Department of Endoscopy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China

    1 shared publication
  • Jian Wei

    Department of Joint Orthopedics, Liuzhou People's Hospital Affiliated to Guangxi Medical University, 8 Wenchang Road, Liuzhou, Guangxi, 545006, P. R. China.

    1 shared publication
  • Qi Li

    Department of Orthopaedic Surgery, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China

    1 shared publication
  • Qiming Liu

    Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China

    1 shared publication
  • Qunbo Meng

    Department of Orthopaedic Surgery, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China

    1 shared publication
  • Shao Liu

    Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China

    1 shared publication

Latest Publications

  • Open Access

    Hepatic GPR110 plays a complex and context-dependent role in metabolic dysfunction-associated steatotic liver disease

    by Yongguo Dai, Hanwen Gu, Xufeng Li, Zixi Zhang, Chao Huang, Yueping Jiang, Xiaoping Chen, Shao Liu

  • Open Access

    Identification and verification of oxidative stress-related genes in the diagnosis of osteoporosis

    by Zhenchuan Liu, Xu Yang, Zexin Wang, Qi Li, Hanwen Gu, Qunbo Meng, Yuanqiang Zhang

    The association between oxidative stress and osteoporosis (OP) has been substantiated by numerous studies; however, the precise underlying mechanism remains elusive. Hence, we employed bioinformatics methodologies to investigate this phenomenon. OP-related datasets (GSE56815 and GSE7158) were utilized in this study. Key module genes linked to oxidative stress-related genes (OS-RGs) were acquired through weighted gene coexpression network analysis (WGCNA). By crossing key module genes and differentially expressed genes (DEGs) from differential expression analysis, candidate genes were obtained. Subsequently, diagnostic genes were obtained through receiver operating characteristic (ROC) curve analysis and expression evaluation. Furthermore, a nomogram model was developed utilizing these genes to assess the collective predictive capacity of the diagnostic genes for OP comprehensively. Additionally, gene set variation analysis (GSVA), immune analysis, and construction of a molecular regulatory network were implemented to further understand the mechanism of the diagnostic genes in OP. We also preliminarily verified the effect of NAPG on osteogenic differentiation through experiments such as ALP, ARS and Western Blot. A total of 101 candidate genes were identified by crossing 395 DEGs and 1,730 key module genes. Importantly, NAPG, NCOA1, and TRIM44 were identified as diagnostic genes associated with oxidative stress in OP. The nomogram model showed the potential predictive ability of OP. Moreover, the GSVA results demonstrated that low expression of NAPG, NCOA1, and TRIM44 was enriched in the oestrogen response early signalling pathway. Moreover, these diagnostic genes were strongly correlated with multiple immune-related genes in the two datasets. Additionally, we identified several important factors that have regulatory relationships with diagnostic genes, such as MEF2A, STAT3, YY1, CREB1, hsa-mir-132-3p, and hsa-mir-148a-3p. Finally, it was verified at the protein and cellular levels that NAPG inhibits osteogenic differentiation and may play a crucial role in osteoporosis. NAPG, NCOA1, and TRIM44 were found to be associated with the diagnosis of OP, suggesting novel opportunities for diagnosing and treating OP.


  • Peiminine regulates bone‐fat balance by canonical Wnt/β‐catenin pathway in an ovariectomized rat model

    by Hanwen Gu, Jian Wei

    Peiminine is a major biologically active component of Fritillaria thunbergii Miq that exhibits good anticancer, antiinflammatory, and anti‐osteoclast effects. However, its effects on osteoporosis (OP) remain unknown. This study aimed to explore whether Peiminine was able to regulate osteogenesis and adipogenesis in ovariectomized (OVX) rat. The effects on the differentiation of bone marrow stem cells (BMSCs), function of Wnt/β‐catenin pathway, ALP activity, calcium nodule deposition, as well as adipocyte formation in vitro by Peiminine at different concentrations, were detected. The curative effects of Peiminine on the ovariectomy‐induced osteoporosis model by micro‐CT and bone histomorphology assays were analyzed. The promotion of osteogenic differentiation and inhibition of adipogenic differentiation by Peiminine (5–40 μg/mL) was detected and the optimum concentration was 20 μg/mL. Mechanistically, Peiminine regulated the fate of BMSCs in vitro, and activated Wnt/β‐catenin signaling pathway by restraining phosphorylation of β‐catenin and promoting the nuclear translocation of β‐catenin. Moreover, Peiminine prevented ovariectomy‐induced osteoporosis by alleviating trabecular bone loss and inhibiting adipose formation. Our data suggested that Peiminine could attenuate ovariectomy‐induced osteoporosis by alleviating trabecular bone loss and inhibiting adipose formation. These encouraging discoveries could lay the foundation for Peiminine to be a promising preventive treatment strategy for skeletal diseases, such as osteoporosis.